TransMedics Group

YTD

ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform.

CEO

Waleed H. Hassanein

CEOWaleed H. Hassanein

Employees

728

Employees728

Headquarters

Andover, Massachusetts

HeadquartersAndover, Massachusetts

Founded

1998

Founded1998

Employees

728

Employees728

TMDX Key Statistics

Market cap

4.07B

Market cap4.07B

Price-Earnings ratio

62.12

Price-Earnings ratio62.12

Dividend yield

—

Dividend yield—

Average volume

888.54K

Average volume888.54K

High today

$124.87

High today$124.87

Low today

$117.00

Low today$117.00

Open price

$120.60

Open price$120.60

Volume

897.54K

Volume897.54K

52 Week high

$145.50

52 Week high$145.50

52 Week low

$55.00

52 Week low$55.00

TMDX News

Simply Wall St 5d

TransMedics Group: Evaluating Valuation Following Analyst Upgrades and Positive Technical Signals

TransMedics Group (TMDX) has been drawing attention after a series of analyst upgrades and improved technical signals. The company’s recent uptick in Relative S...

Simply Wall St 6d

The Bull Case For TransMedics Group Could Change Following Analyst Upgrades and Shifting Technical Sentiment

TransMedics Group recently announced plans to release its third quarter 2025 financial results and host an investor conference call on October 29, 2025, further...

Analyst ratings

77%

of 13 ratings

Buy

76.9%

Hold

23.1%

Sell

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Hims & Hers Health

Rocket Lab Corporation